Paul is a member of Reed Smith’s Life Sciences Health Industry Group. He advises health care providers and life science companies on regulatory matters and business transactions. This often includes providing clients with guidance on fraud and abuse laws, payment and coverage rules, privacy and security laws, and participation in Medicare and Medicaid programs. Paul has worked with a wide range of health care providers and life science companies, and has particularly deep industry experience in radiology, radiation oncology, telemedicine and long-term care.
With a focus on finding practical solutions, Paul advises health care providers and life science companies on business and regulatory considerations in transactions and contractual arrangements. He has extensive experience in negotiating and drafting agreements between health care providers, forming joint ventures, and advising start-ups. He has represented buyers and sellers in major acquisitions in the life sciences and health care industry, focusing on due diligence, change of ownership issues, regulatory approvals and related regulatory issues.
Paul has conducted internal investigations on behalf of health care providers alleged to have submitted false claims to federal health care programs. He has represented hospitals and imaging centers in disclosing and refunding Medicare overpayments and in defending false claim investigations brought by the Department of Justice and Office of Inspector General.